X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3205) 3205
Book Chapter (182) 182
Dissertation (13) 13
Publication (5) 5
Magazine Article (4) 4
Book / eBook (3) 3
Web Resource (2) 2
Book Review (1) 1
Government Document (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
antibiotic therapy (2049) 2049
humans (1450) 1450
science & technology (1088) 1088
life sciences & biomedicine (1080) 1080
female (859) 859
male (818) 818
anti-bacterial agents - therapeutic use (584) 584
middle aged (575) 575
adult (504) 504
aged (478) 478
antibiotics (416) 416
infectious diseases (365) 365
treatment outcome (250) 250
microbiology (244) 244
anti-bacterial agents - administration & dosage (241) 241
retrospective studies (199) 199
animals (197) 197
antibiotics, antineoplastic - administration & dosage (196) 196
adolescent (188) 188
pharmacology & pharmacy (188) 188
general & internal medicine (185) 185
surgery (176) 176
risk factors (172) 172
aged, 80 and over (171) 171
child (169) 169
health aspects (161) 161
medicine (156) 156
antibiotics, antineoplastic - therapeutic use (155) 155
infection (149) 149
pediatrics (147) 147
prospective studies (146) 146
medicine & public health (134) 134
pneumonia (133) 133
care and treatment (124) 124
infections (124) 124
drug therapy (121) 121
mortality (121) 121
drug administration schedule (117) 117
drug therapy, combination (117) 117
sepsis (112) 112
child, preschool (111) 111
medicine, general & internal (106) 106
abridged index medicus (105) 105
infant (104) 104
children (100) 100
patients (99) 99
time factors (99) 99
bacterial infections - drug therapy (97) 97
analysis (91) 91
anti-bacterial agents - pharmacology (91) 91
diagnosis (91) 91
young adult (88) 88
prognosis (85) 85
antibiotic resistance (83) 83
anti-bacterial agents - adverse effects (82) 82
mice (82) 82
critical care medicine (81) 81
acute disease (79) 79
research (77) 77
community-acquired pneumonia (76) 76
internal medicine (76) 76
antibiotics/therapy (75) 75
cystic fibrosis (75) 75
empirical antibiotic therapy (75) 75
respiratory system (74) 74
staphylococcus aureus (73) 73
follow-up studies (72) 72
immunology (72) 72
microbial sensitivity tests (72) 72
bacterial infections (71) 71
practice guidelines as topic (70) 70
therapy (70) 70
combined modality therapy (69) 69
oncology (69) 69
old medline (68) 68
bacteria (66) 66
drug resistance (65) 65
infant, newborn (65) 65
antibiotic prophylaxis (64) 64
antibiothérapie (63) 63
staphylococcal infections - drug therapy (63) 63
anti-bacterial agents (62) 62
community-acquired infections - drug therapy (62) 62
hospitals (60) 60
outpatient parenteral antibiotic therapy (59) 59
pseudomonas aeruginosa (59) 59
usage (59) 59
bacteremia (57) 57
cross infection - drug therapy (57) 57
drug resistance, bacterial (57) 57
antineoplastic combined chemotherapy protocols - therapeutic use (56) 56
cohort studies (56) 56
empiric antibiotic therapy (56) 56
pneumonia, bacterial - drug therapy (56) 56
infectious and parasitic diseases (55) 55
mitomycin (55) 55
osteomyelitis (54) 54
dosage and administration (53) 53
urinary tract infection (53) 53
antibiotics, antineoplastic - adverse effects (52) 52
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2216) 2216
Japanese (456) 456
German (218) 218
French (194) 194
Chinese (110) 110
Russian (110) 110
Spanish (66) 66
Italian (60) 60
Polish (40) 40
Czech (31) 31
Portuguese (27) 27
Turkish (9) 9
Hungarian (5) 5
Korean (5) 5
Dutch (4) 4
Slovak (4) 4
Persian (3) 3
Serbian (3) 3
Ukrainian (2) 2
Azerbaijani (1) 1
Catalan (1) 1
Danish (1) 1
Hebrew (1) 1
Lithuanian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Nuclear Medicine, ISSN 0161-5505, 11/2017, Volume 58, Issue 11, pp. 1827 - 1830
Journal Article
Chest, ISSN 0012-3692, 04/2016, Volume 149, Issue 4, pp. 1052 - 1060
Background Chronic cough is a common clinical problem worldwide. Although many patients have underlying precipitating conditions such as asthma,... 
Pulmonary/Respiratory | airway inflammation | cough | antibiotic therapy
Journal Article
The Journal of the American Dental Association (JADA), ISSN 0002-8177, 2016, Volume 147, Issue 7, pp. 577 - 585
Abstract Background The goal in treating refractory periodontitis (RP) is to arrest or slow disease progression, which usually has included the use of systemic... 
Dentistry | Periodontitis | systemic antibiotic therapy | periodontal treatment
Journal Article
World journal of emergency surgery, ISSN 1749-7922, 01/2018, Volume 13, Issue 1, pp. 5 - 5
Journal Article
Journal Article
Giornale italiano di endodonzia, ISSN 1121-4171, 2019, Volume 33, Issue 1, pp. 21 - 26
Journal Article
Current infectious disease reports, ISSN 1523-3847, 10/2012, Volume 14, Issue 5, pp. 566 - 575
Chronic osteomyelitis is a multifaceted bacterial infection with common features. It absolutely requires surgery for remission. The duration and form of... 
Osteomyelitis | Recurrence | Duration | Penetration | Surgery | Antibiotic therapy | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Antibiotics | Bacterial infections
Journal Article
Gut, ISSN 0017-5749, 11/2013, Volume 62, Issue 11, pp. 1591 - 1601
Objective Antibiotic (AB) usage strongly affects microbial intestinal metabolism and thereby impacts human health. Understanding this process and the... 
metaproteomics | database | prokaryotes | human fecal microbiota | perturbation | metabolism | human intestinal microbiota | long-term impacts | community | resistance | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Humans | RNA, Ribosomal, 16S - analysis | Bacteria - drug effects | Microbiota - drug effects | Gastrointestinal Tract - microbiology | Gene Expression Profiling - methods | Male | Biodiversity | Bacterial Typing Techniques - methods | Gastrointestinal Tract - metabolism | RNA, Bacterial - analysis | Gene Expression Regulation - drug effects | Feces - microbiology | Bacteria - isolation & purification | beta-Lactams - pharmacology | Metabolome - drug effects | Bacteria - classification | DNA, Bacterial - analysis | Aged | Anti-Bacterial Agents - pharmacology | Beta lactam antibiotics | Influence | Usage | Research | Microbiota (Symbiotic organisms) | High performance liquid chromatography | Health care | Bacterial infections | Ecosystems | Laboratories | Infections | Gene expression | Ecosystem biology | Studies | Proteins | Nutrition research | Metabolites | Antibiotics | Bacteria | Physiology | Metabolic disorders | Deoxyribonucleic acid--DNA | Index Medicus | Abridged Index Medicus | Meta-Analysis | Gene Expression | Gastrointestinal Function | Gut Microbiota | Colonic Microflora | 1506 | Antibiotic Therapy
Journal Article
Zentralblatt für Chirurgie - Zeitschrift für Allgemeine, Viszeral-, Thorax- und Gefäßchirurgie, ISSN 0044-409X, 10/2013, Volume 138, Issue 5, pp. 549 - 553
Zusammenfassung Bei nosokomialen Infektionen in deutschen Kliniken werden vermehrt gramnegative Erreger isoliert, die infolge ihrer zunehmenden Resistenz... 
Übersicht | multiresistance | antibiotic therapy | Enterobacteriaceae
Journal Article
Gut, ISSN 0017-5749, 09/2016, Volume 65, Issue 9, pp. 1439 - 1446
ObjectiveThe objective of this study was to assess the efficacy, safety and tolerability of vonoprazan, a novel potassium-competitive acid blocker, as a... 
antibiotic therapy | clinical trials | Helicobacter pylori infection | helicobacter pylori - treatment | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Humans | Middle Aged | Helicobacter Infections - complications | Helicobacter pylori - drug effects | Male | Drug Monitoring - methods | Proton Pump Inhibitors - administration & dosage | Pyrroles - administration & dosage | Helicobacter Infections - drug therapy | Clarithromycin - administration & dosage | Metronidazole - adverse effects | Peptic Ulcer - diagnosis | Pyrroles - adverse effects | Adult | Female | Amoxicillin - administration & dosage | Anti-Bacterial Agents - adverse effects | Helicobacter Infections - diagnosis | Lansoprazole - administration & dosage | Proton Pump Inhibitors - adverse effects | Double-Blind Method | Drug Administration Schedule | Clarithromycin - adverse effects | Metronidazole - administration & dosage | Treatment Outcome | Drug Therapy, Combination - methods | Lansoprazole - adverse effects | Sulfonamides - adverse effects | Amoxicillin - adverse effects | Helicobacter pylori - isolation & purification | Anti-Bacterial Agents - administration & dosage | Peptic Ulcer - drug therapy | Breath Tests - methods | Peptic Ulcer - etiology | Sulfonamides - administration & dosage | Usage | Safety and security measures | Research | Helicobacter pylori | Antacids | Index Medicus | Abridged Index Medicus | Helicobacter Pylori | HELICOBACTER PYLORI - TREATMENT | CLINICAL TRIALS | 1506 | ANTIBIOTIC THERAPY | HELICOBACTER PYLORI INFECTION
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 06/2015, Volume 60, Issue 11, pp. 1622 - 1630
Background. To prevent inappropriate empiric antibiotic treatment in patients with bacteremia caused by third-generation cephalosporin (3GC)-resistant... 
extended-spectrum beta-lactamases | risk factors | AMERICA | ESCHERICHIA-COLI | GUIDELINES | RISK | carbapenems | SOCIETY | INFECTIOUS-DISEASES | THERAPY | COMMUNITY | empiric antibiotic therapy | LACTAMASE-PRODUCING ENTEROBACTERIACEAE | inappropriate antibiotic therapy | EPIDEMIOLOGY | extended-spectrum β-lactamases | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Predictive Value of Tests | beta-Lactam Resistance | Humans | Middle Aged | Male | Enterobacteriaceae - isolation & purification | Drug Utilization | Young Adult | Anti-Bacterial Agents - therapeutic use | Enterobacteriaceae Infections - epidemiology | Sepsis - drug therapy | Netherlands | Aged, 80 and over | Adult | Female | Retrospective Studies | Cephalosporins - pharmacology | Enterobacteriaceae Infections - microbiology | Sepsis - epidemiology | Guideline Adherence | Epidemiologic Methods | Adolescent | Enterobacteriaceae - drug effects | Aged | Anti-Bacterial Agents - pharmacology | Sepsis - microbiology | Enterobacteriaceae Infections - drug therapy | Moxalactam | Care and treatment | Cephalosporins | Analysis | Practice guidelines (Medicine) | Sepsis | Cephaloridine | Dosage and administration | Research | Carbapenems | Multidrug resistant organisms | Antibiotics | Medical treatment | Index Medicus
Journal Article